[1]
|
Roman-Gomez, J., Jimenez-Velasco, A., Castillejo, J.A., Agirre, X., et al. (2004) Promoter Hypermethylation of Cancer-Related Genes: A Strong Independent Prognostic Factor in Acute Lymphoblastic Leukemia. Blood, 104, 2492-2498. http://dx.doi.org/10.1182/blood-2004-03-0954
|
[2]
|
Rossi, D., Capello, D., Gloghini, A., Franceschetti, S., et al. (2004) Aberrant Promoter Methylation of Multiple Genes throughout the Clinico-Pathologic Spectrum of B-Cell Neoplasia. Haematologica, 89, 154-64.
|
[3]
|
Jabbour, E., Issa, J.P., Garcia-Manero, G. and Kantarjian, H. (2008) Evolution of Decitabine Development: Accomplishments, Ongoing Investigations, and Future Strategies. Cancer, 112, 2341-2351. http://dx.doi.org/10.1002/cncr.23463
|
[4]
|
Schmelz, K., Wagner, M., Dorken, B. and Tamm, I. (2005) 5-Aza-2'-deoxycytidine Induces p21WAF Expression by Demethylation of p73 Leading to p53-Independent Apoptosis in Myeloid Leukemia. International Journal of Cancer, 114, 683-695. http://dx.doi.org/10.1002/ijc.20797
|
[5]
|
Wijermans, P., Lubbert, M., Verhoef, G., Bosly, A., et al. (2000) Low-dose 5-Aza-2'-deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients. Journal of Clinical Oncology, 18, 956-962.
|
[6]
|
Kantarjian, H.M., O’Brien, S., Cortes, J., Giles, F.J., et al. (2003) Results of Decitabine (5-Aza-2'deoxycytidine) Therapy in 130 Patients with Chronic Myelogenous Leukemia. Cancer, 98, 522-528. http://dx.doi.org/10.1002/cncr.11543
|
[7]
|
Khan, H., Vale, C., Bhagat, T. and Verma, A. (2013) Role of DNA Methylation in the Pathogenesis and Treatment of Myelodysplastic Syndromes. Seminars in Hematology, 50, 16-37. http://dx.doi.org/10.1053/j.seminhematol.2013.01.001
|
[8]
|
Blum, W., Klisovic, R.B., Hackanson, B., Liu, Z., et al. (2007) Phase I Study of Decitabine Alone or in Combination with Valproic Acid in Acute Myeloid Leukemia. Journal of Clinical Oncology, 25, 3884-3891. http://dx.doi.org/10.1200/JCO.2006.09.4169
|
[9]
|
Cashen, A.F., Schiller, G.J., O’Donnell, M.R. and DiPersio, J.F. (2010) Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients with Acute Myeloid Leukemia. Journal of Clinical Oncology, 28, 556-561. http://dx.doi.org/10.1200/JCO.2009.23.9178
|
[10]
|
Plimack, E.R., Kantarjian, H.M. and Issa, J.P. (2007) Decitabine and Its Role in the Treatment of Hematopoietic Malignancies. Leukemia & Lymphoma, 48, 1472-1481. http://dx.doi.org/10.1080/10428190701471981
|
[11]
|
Malik, P. and Cashen, A.F. (2014) Decitabine in the Treatment of Acute Myeloid Leukemia in Elderly Patients. Cancer Management and Research, 6, 53-61.
|
[12]
|
Ho, S.Y., Wu Jr., W., Chiu, H.W., et al. (2011) Arsenic Trioxide and Radiation Enhance Apoptotic Effects in HL-60 Cells through Increased ROS Generation and Regulation of JNK and p38 MAPK Signaling Pathways. Chemico-Biological Interactions, 193, 162-171. http://dx.doi.org/10.1016/j.cbi.2011.06.007
|
[13]
|
Zhao, D., Jiang, Y., Dong, X., et al. (2011) Arsenic Trioxide Reduces Drug Resistance to Adriamycin in Leukemic K562/A02 Cells via Multiple Mechanisms. Biomedicine & Pharmacotherapy, 65, 354-358. http://dx.doi.org/10.1016/j.biopha.2011.04.016
|
[14]
|
Yang, L., Luo, J.M., Li, Y., et al. (2009) As2O3 Induces Demethylation and Upregulates Transeription of SHP-1 Gene in Human Lymphoma Cell Line T2 Cells. Chinese Journal of Oncology, 31, 423-427.
|
[15]
|
Gandesiri, M., Chakilam, S., Ivanovska, J., Benderska, N., et al. (2012) DAPK Plays an Important Role in Panobinostat-Induced Autophagy and Commits Cells to Apoptosis under Autophagy Deficient Conditions. Apoptosis, 17, 1300-1315. http://dx.doi.org/10.1007/s10495-012-0757-7
|
[16]
|
Gade, P., Ramachandran, G., Maachani, U.B., Rizzo, M.A., et al. (2012) An IFN-Gamma-Stimulated ATF6-C/EBP-Beta-Signaling Pathway Critical for the Expression of Death Associated Protein Kinase 1 and Induction of Autophagy. Proceedings of the National Academy of Sciences of the United States of America, 109, 10316-10321. http://dx.doi.org/10.1073/pnas.1119273109
|
[17]
|
Schneider-Stock, R., Kuester, D., Ullrich, O., Mittag, F., et al. (2006) Close Localization of DAP-Kinase Positive Tumour-Associated Macrophages and Apoptotic Colorectal Cancer Cells. Journal of Pathology, 209, 95-105. http://dx.doi.org/10.1002/path.1951
|
[18]
|
Luo, X.J., Li, L.L., Deng, Q.P., Yu, X.F., et al. (2011) Grifolin, a Potent Antitumour Natural Product Upregulates Death-Associated Protein Kinase 1 DAPK1 via p53 in Nasopharyngeal Carcinoma Cells. European Journal of Cancer, 47, 316-325. http://dx.doi.org/10.1016/j.ejca.2010.09.021
|
[19]
|
Inbal, B., Bialik, S., Sabanay, I., Shani, G., et al. (2002) DAP Kinase and DRP-1 Mediate Membrane Blebbing and the Formation of Autophagic Vesicles during Programmed Cell Death. Journal of Cell Biology, 157, 455-468. http://dx.doi.org/10.1083/jcb.200109094
|
[20]
|
Eisenberg-Lerner, A. and Kimchi, A. (2007) DAP Kinase Regulates JNK Signaling by Binding and Activating Protein Kinase D under Oxidative Stress. Cell Death & Differentiation, 14, 1908-1915. http://dx.doi.org/10.1038/sj.cdd.4402212
|
[21]
|
Tahara, T., Shibata, T., Nakamura, M., Okubo, M., et al. (2011) Polymorphisms of DNA Repair and Xenobiotic Genes Predispose to CpG Island Methylation in Non-Neoplastic Gastric Mucosa. Helicobacter, 16, 99-106. http://dx.doi.org/10.1111/j.1523-5378.2011.00821.x
|
[22]
|
Su, Y., Xu, H., Xu, Y., Yu, J., et al. (2012) Azacytidine Inhibits the Proliferation of Human Promyelocytic Leukemia Cells (HL60) by Demethylation of MGMT, DAPK and p16 Genes. Hematology, 17, 41-46. http://dx.doi.org/10.1179/102453312X13221316477624
|
[23]
|
Niu, Y.M., Wang, P.P., Wang, Y., Wang, Y.Z., et al. (2014) Expression of Death-Associated Protein Kinase Gene and Methylation Status of Promoter Region in Acute Leukemia. Journal of Experimental Hematology, 22, 30-34.
|
[24]
|
Liu, X.F., Tang, K., Yu, S.P., Wang, Z.Q., et al. (2012) Correlation between Promoter Methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 Mutation with Prognosis in Cholangiocarcinoma. World Journal of Surgical Oncology, 10, 5. http://dx.doi.org/10.1186/1477-7819-10-5
|
[25]
|
Liu, Y., Gao, W., Siegfried, J.M., Weissfeld, J.L., et al. (2007) Promoter Methylation of RASSF1A and DAPK and Mutations of K-ras, p53, and EGFR in Lung Tumors from Smokers and Never-Smokers. BMC Cancer, 7, 74. http://dx.doi.org/10.1186/1471-2407-7-74
|
[26]
|
Wu, J., Hu, C.P., Gu, Q.H., Li, Y.P., et al. (2010) Trichostatin A Sensitizes Cisplatin-Resistant A549 Cells to Apoptosis by Up-Regulating Death-Associated Protein Kinase. Acta Pharmacologica Sinica, 31, 93-101. http://dx.doi.org/10.1038/aps.2009.183
|
[27]
|
Nair, S., Hagberg, H., Krishnamurthy, R., Thornton, C., et al. (2013) Death Associated Protein Kinases: Molecular Structure and Brain Injury. International Journal of Molecular Sciences, 14, 13858-13872. http://dx.doi.org/10.3390/ijms140713858
|
[28]
|
Widau, R.C., Jin, Y., Dixon, S.A., Wadzinski, B.E., et al. (2010) Protein Phosphatase 2A (PP2A) Holoenzymes Regulate Death-Associated Protein Kinase (DAPK) in Ceramide-Induced Anoikis. Journal of Biological Chemistry, 285, 13827-13838. http://dx.doi.org/10.1074/jbc.M109.085076
|
[29]
|
Soncini, M., Santoro, F., Gutierrez, A., Frige, G., et al. (2013) The DNA Demethylating Agent Decitabine Activates the TRAIL Pathway and Induces Apoptosis in Acute Myeloid Leukemia. Biochimica et Biophysica Acta, 1832, 114-120. http://dx.doi.org/10.1016/j.bbadis.2012.10.001
|
[30]
|
Ge, F., Lu, X.P., Zeng, H.L., He, Q.Y., et al. (2009) Proteomic and Functional Analyses Reveal a Dual Molecular Mechanism Underlying Arsenic-Induced Apoptosis in Human Multiple Myeloma Cells. Journal of Proteome Research, 8, 3006-3019. http://dx.doi.org/10.1021/pr9001004
|
[31]
|
Morales, A.A., Gutman, D., Cejas, P.J., Lee, K.P., et al. (2009) Reactive Oxygen Species Are Not Required for an Arsenic Trioxide-Induced Antioxidant Response or Apoptosis. Journal of Biological Chemistry, 284, 12886-12895. http://dx.doi.org/10.1074/jbc.M806546200
|